Small drugmakers plunging into deeper slump

Korea’s small and medium-sized posted sharp declines in their second-quarter operating profits, adding further anxiety to their already troubled financial health.

Analysts said sluggish demand for generic drugs and sales at cheaper prices were to blame for the poor performances.

Rumors are spreading that some small companies plan to sell their plants to keep their business afloat and th...